Securitas Biosciences Group
Overview
Securitas Biosciences Group is a venture studio and holding company founded in 2019 that seeks to invest in molecular and cellular therapies, life sciences applied artificial intelligence, and niche pharma laboratory sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| VirTech Bio | Nov 2022 | Seed | Co-investor |
Key People
Luis Claudio Garcia de Souza
Co-Founder Chairman
Hugo Cabrera
Entrepreneur in Residence, Operational Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Securitas Biosciences Group based?
Securitas Biosciences Group is headquartered in São Paulo, Brazil.
When was Securitas Biosciences Group founded?
Securitas Biosciences Group was founded in 2019.
How many portfolio companies does Securitas Biosciences Group have?
Securitas Biosciences Group has 1 portfolio company in Caplight's dataset.
What are some companies in Securitas Biosciences Group's portfolio?
Portfolio companies visible on Caplight include VirTech Bio.
What was Securitas Biosciences Group's most recent investment shown here?
Securitas Biosciences Group's most recent investment in this portfolio sample was in VirTech Bio in 2022.
What sectors does Securitas Biosciences Group focus on?
Securitas Biosciences Group focuses on Healthcare & Life Sciences.
What company stages does Securitas Biosciences Group focus on?
Securitas Biosciences Group typically invests at the Early stage.